244 related articles for article (PubMed ID: 14514646)
21. NADPH Oxidase Nox5 Accelerates Renal Injury in Diabetic Nephropathy.
Jha JC; Banal C; Okabe J; Gray SP; Hettige T; Chow BSM; Thallas-Bonke V; De Vos L; Holterman CE; Coughlan MT; Power DA; Skene A; Ekinci EI; Cooper ME; Touyz RM; Kennedy CR; Jandeleit-Dahm K
Diabetes; 2017 Oct; 66(10):2691-2703. PubMed ID: 28747378
[TBL] [Abstract][Full Text] [Related]
22. Protein kinase C beta inhibitor LY333531 attenuates intercellular adhesion molecule-1 and monocyte chemotactic protein-1 expression in the kidney in diabetic rats.
Wu Y; Wu G; Qi X; Lin H; Qian H; Shen J; Lin S
J Pharmacol Sci; 2006 Aug; 101(4):335-43. PubMed ID: 16891764
[TBL] [Abstract][Full Text] [Related]
23. Reactive oxygen species mediate high glucose-induced plasminogen activator inhibitor-1 up-regulation in mesangial cells and in diabetic kidney.
Lee EA; Seo JY; Jiang Z; Yu MR; Kwon MK; Ha H; Lee HB
Kidney Int; 2005 May; 67(5):1762-71. PubMed ID: 15840023
[TBL] [Abstract][Full Text] [Related]
24. AGEs induce oxidative stress and activate protein kinase C-beta(II) in neonatal mesangial cells.
Scivittaro V; Ganz MB; Weiss MF
Am J Physiol Renal Physiol; 2000 Apr; 278(4):F676-83. PubMed ID: 10751230
[TBL] [Abstract][Full Text] [Related]
25. Cellular mechanisms in the development and progression of diabetic nephropathy: activation of the DAG-PKC-ERK pathway.
Haneda M; Koya D; Kikkawa R
Am J Kidney Dis; 2001 Oct; 38(4 Suppl 1):S178-81. PubMed ID: 11576950
[TBL] [Abstract][Full Text] [Related]
26. Induction and activation by zinc of NADPH oxidase in cultured cortical neurons and astrocytes.
Noh KM; Koh JY
J Neurosci; 2000 Dec; 20(23):RC111. PubMed ID: 11090611
[TBL] [Abstract][Full Text] [Related]
27. Ethyl pyruvate ameliorates albuminuria and glomerular injury in the animal model of diabetic nephropathy.
Ju KD; Shin EK; Cho EJ; Yoon HB; Kim HS; Kim H; Yang J; Hwang YH; Ahn C; Oh KH
Am J Physiol Renal Physiol; 2012 Mar; 302(5):F606-13. PubMed ID: 22129969
[TBL] [Abstract][Full Text] [Related]
28. High glucose-induced RhoA activation requires caveolae and PKCĪ²1-mediated ROS generation.
Zhang Y; Peng F; Gao B; Ingram AJ; Krepinsky JC
Am J Physiol Renal Physiol; 2012 Jan; 302(1):F159-72. PubMed ID: 21975875
[TBL] [Abstract][Full Text] [Related]
29. Activation of protein kinase c-delta and c-epsilon by oxidative stress in early diabetic rat kidney.
Ha H; Yu MR; Choi YJ; Lee HB
Am J Kidney Dis; 2001 Oct; 38(4 Suppl 1):S204-7. PubMed ID: 11576956
[TBL] [Abstract][Full Text] [Related]
30. Inhibition of NADPH oxidase prevents advanced glycation end product-mediated damage in diabetic nephropathy through a protein kinase C-alpha-dependent pathway.
Thallas-Bonke V; Thorpe SR; Coughlan MT; Fukami K; Yap FY; Sourris KC; Penfold SA; Bach LA; Cooper ME; Forbes JM
Diabetes; 2008 Feb; 57(2):460-9. PubMed ID: 17959934
[TBL] [Abstract][Full Text] [Related]
31. High glucose activates PKC-zeta and NADPH oxidase through autocrine TGF-beta1 signaling in mesangial cells.
Xia L; Wang H; Munk S; Kwan J; Goldberg HJ; Fantus IG; Whiteside CI
Am J Physiol Renal Physiol; 2008 Dec; 295(6):F1705-14. PubMed ID: 18815221
[TBL] [Abstract][Full Text] [Related]
32. The mTOR promotes oxidative stress-induced apoptosis of mesangial cells in diabetic nephropathy.
Lu Q; Zhou Y; Hao M; Li C; Wang J; Shu F; Du L; Zhu X; Zhang Q; Yin X
Mol Cell Endocrinol; 2018 Sep; 473():31-43. PubMed ID: 29277549
[TBL] [Abstract][Full Text] [Related]
33. A PKC-beta inhibitor protects against cardiac microvascular ischemia reperfusion injury in diabetic rats.
Wei L; Sun D; Yin Z; Yuan Y; Hwang A; Zhang Y; Si R; Zhang R; Guo W; Cao F; Wang H
Apoptosis; 2010 Apr; 15(4):488-98. PubMed ID: 20044781
[TBL] [Abstract][Full Text] [Related]
34. Specific retinal diacylglycerol and protein kinase C beta isoform modulation mimics abnormal retinal hemodynamics in diabetic rats.
Bursell SE; Takagi C; Clermont AC; Takagi H; Mori F; Ishii H; King GL
Invest Ophthalmol Vis Sci; 1997 Dec; 38(13):2711-20. PubMed ID: 9418723
[TBL] [Abstract][Full Text] [Related]
35. Effects on protein kinase C-beta inhibition on glomerular vascular endothelial growth factor expression and endothelial cells in advanced experimental diabetic nephropathy.
Kelly DJ; Buck D; Cox AJ; Zhang Y; Gilbert RE
Am J Physiol Renal Physiol; 2007 Aug; 293(2):F565-74. PubMed ID: 17522264
[TBL] [Abstract][Full Text] [Related]
36. Effects of antioxidants in diabetes-induced oxidative stress in the glomeruli of diabetic rats.
Koya D; Hayashi K; Kitada M; Kashiwagi A; Kikkawa R; Haneda M
J Am Soc Nephrol; 2003 Aug; 14(8 Suppl 3):S250-3. PubMed ID: 12874441
[TBL] [Abstract][Full Text] [Related]
37. Inhibition of protein kinase C-beta by ruboxistaurin preserves cardiac function and reduces extracellular matrix production in diabetic cardiomyopathy.
Connelly KA; Kelly DJ; Zhang Y; Prior DL; Advani A; Cox AJ; Thai K; Krum H; Gilbert RE
Circ Heart Fail; 2009 Mar; 2(2):129-37. PubMed ID: 19808328
[TBL] [Abstract][Full Text] [Related]
38. Suppressing renal NADPH oxidase to treat diabetic nephropathy.
Tojo A; Asaba K; Onozato ML
Expert Opin Ther Targets; 2007 Aug; 11(8):1011-8. PubMed ID: 17665974
[TBL] [Abstract][Full Text] [Related]
39. Activation of nicotinamide adenine dinucleotide phosphate (reduced form) oxidase by advanced glycation end products links oxidative stress to altered retinal vascular endothelial growth factor expression.
Li L; Renier G
Metabolism; 2006 Nov; 55(11):1516-23. PubMed ID: 17046555
[TBL] [Abstract][Full Text] [Related]
40. Protein kinase C beta inhibition attenuates the progression of experimental diabetic nephropathy in the presence of continued hypertension.
Kelly DJ; Zhang Y; Hepper C; Gow RM; Jaworski K; Kemp BE; Wilkinson-Berka JL; Gilbert RE
Diabetes; 2003 Feb; 52(2):512-8. PubMed ID: 12540629
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
